Literature DB >> 18515590

Association analysis of CFH, C2, BF, and HTRA1 gene polymorphisms in Chinese patients with polypoidal choroidal vasculopathy.

Kelvin Y Lee1, Eranga N Vithana, Ranjana Mathur, Victor H Yong, Ian Y Yeo, Anbupalam Thalamuthu, Mun-Wai Lee, Adrian H Koh, Marcus C Lim, Alicia C How, Doric W Wong, Tin Aung.   

Abstract

PURPOSE: Polypoidal choroidal vasculopathy (PCV) is a major cause of serosanguinous maculopathy in Chinese patients with age-related macular degeneration (AMD). Variants in the CFH and HTRA1/LOC387715 genes are strongly associated with AMD in Caucasians and Chinese. Variants in the C2 and BF genes have been found to confer a significantly reduced risk of AMD. This study was undertaken to determine whether these associations occur in Chinese patients with PCV.
METHODS: Patients of Chinese ethnicity with clinically and angiographically diagnosed PCV and normal control subjects were recruited from the Singapore National Eye Centre. Five single-nucleotide polymorphisms (SNPs) in the CFH gene, two each within the C2 and BF genes and two variants located in the LOC387715 and HTRA1 genes, were screened in all patients and control subjects.
RESULTS: Seventy-two patients with PCV and 93 normal control subjects were studied. A significant association was noted with CFH variants rs3753394 and rs800292 among the PCV cases (P = 0.0015 and P = 0.0045, respectively). Individuals homozygous for the TT genotype of rs3753394 had a significantly higher risk (P = 0.0076) of PCV (OR = 4.29; 95% CI: 1.47-12.50) than those carrying a single copy of the T allele (P = 0.3210; OR = 1.69; 95% CI: 0.60-4.78), after adjustment for such risk factors as age and sex. The genotype frequencies of rs11200638 and rs10490924 in HTRA1 and LOC387715, respectively, were also found to be significantly different between patients with PCV and normal control subjects (P = 0.00032 and P = 0.003, respectively). The AA genotype of rs11200638 and TT genotype of rs10490924 conferred a 4.9-fold (95% CI: 1.85-12.95) and 4.89-fold (95% CI: 1.85-12.90) increased risk of PCV, respectively, after adjustment for age and sex. The Y402H variant of CFH (rs1061170) and the BF and C2 variants were not significantly different in patients and normal control subjects.
CONCLUSIONS: The SNPs rs3753394 and rs800292 of CFH and rs11200638 of HTRA1 are significantly associated with the risk of PCV in Chinese patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18515590     DOI: 10.1167/iovs.07-0860

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  36 in total

1.  Association of ARMS2/HTRA1 variants with polypoidal choroidal vasculopathy phenotype in a Korean population.

Authors:  Dong Ho Park; In Taek Kim
Journal:  Jpn J Ophthalmol       Date:  2011-09-29       Impact factor: 2.447

2.  Association of complement factor H gene polymorphisms with age-related macular egeneration susceptibility.

Authors:  Xiao-Feng Hao; Li-Ke Xie; You-Zhi Tang; Wan-Kun Xie; Zhi-Fang Zhang; Yi-Xin Qi; Wen-Zheng Xiao; Jing Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

3.  Development of polypoidal lesions in age-related macular degeneration.

Authors:  A Tsujikawa; Y Ojima; K Yamashiro; S Ooto; H Tamura; I Nakata; N Yoshimura
Journal:  Eye (Lond)       Date:  2011-01-21       Impact factor: 3.775

4.  Gene-gene interaction of CFH, ARMS2, and ARMS2/HTRA1 on the risk of neovascular age-related macular degeneration and polypoidal choroidal vasculopathy in Chinese population.

Authors:  L Huang; Q Meng; C Zhang; Y Sun; Y Bai; S Li; X Deng; B Wang; W Yu; M Zhao; X Li
Journal:  Eye (Lond)       Date:  2015-03-13       Impact factor: 3.775

5.  Proteolytic Degradation and Inflammation Play Critical Roles in Polypoidal Choroidal Vasculopathy.

Authors:  Sandeep Kumar; Hiroyuki Nakashizuka; Alex Jones; Alyssia Lambert; Xuchen Zhao; Megan Shen; Mackenzie Parker; Shixian Wang; Zachary Berriochoa; Amrita Fnu; Stephanie VanBeuge; Patricia Chévez-Barrios; Mark Tso; Jon Rainier; Yingbin Fu
Journal:  Am J Pathol       Date:  2017-09-21       Impact factor: 4.307

6.  Plasma biomarkers of oxidative stress and genetic variants in age-related macular degeneration.

Authors:  Milam A Brantley; Melissa P Osborn; Barton J Sanders; Kasra A Rezaei; Pengcheng Lu; Chun Li; Ginger L Milne; Jiyang Cai; Paul Sternberg
Journal:  Am J Ophthalmol       Date:  2011-10-29       Impact factor: 5.258

7.  Genetic risk, ethnic variations and pharmacogenetic biomarkers in age-related macular degeneration and polypoidal choroidal vasculopathy.

Authors:  Jane Z Kuo; Tien Y Wong; Frank S Ong
Journal:  Expert Rev Ophthalmol       Date:  2013-04-01

8.  VEGF gene polymorphism and response to intravitreal bevacizumab and triple therapy in age-related macular degeneration.

Authors:  Isao Nakata; Kenji Yamashiro; Hideo Nakanishi; Akitaka Tsujikawa; Atsushi Otani; Nagahisa Yoshimura
Journal:  Jpn J Ophthalmol       Date:  2011-07-09       Impact factor: 2.447

9.  Shared genetic variants for polypoidal choroidal vasculopathy and typical neovascular age-related macular degeneration in East Asians.

Authors:  Qiao Fan; Chui Ming Gemmy Cheung; Li Jia Chen; Kenji Yamashiro; Jeeyun Ahn; Augustinus Laude; Ranjana Mathur; Chan Choi Mun; Ian Y Yeo; Tock Han Lim; Yik-Ying Teo; Chiea Chuen Khor; Kyu-Hyung Park; Nagahisa Yoshimura; Chi Pui Pang; Tien Yin Wong; Ching-Yu Cheng
Journal:  J Hum Genet       Date:  2017-08-24       Impact factor: 3.172

10.  SERPING1 polymorphisms in polypoidal choroidal vasculopathy.

Authors:  Meng Li; Feng Wen; Chengguo Zuo; Xiongze Zhang; Hui Chen; Shizhou Huang; Guangwei Luo
Journal:  Mol Vis       Date:  2010-02-16       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.